Spore Powder of Ganoderma Lucidum Seminar, aka the 110th Anniversary of the Foundation of ShouXianGu, with the theme of “Revitalize TCM with technological innovation” was held in Hangzhou, Zhejiang on 9th September.
The seminar consisted of two parts: “Review Session of Special Fund Topics on the Clinical Research of TCM Cancer Prevention and Treatment” and “Seminar on the Pharmacological and Clinical Communication of Sporoderm-Removal Ganoderma Lucidum Spore Powder”, aiming to communicate and develop clinical research on TCM cancer prevention and treatment.
This special fund program was jointly initiated by Zhejiang Anti-Cancer Association and ShouXianGu in June 2019, mainly funding clinical experts from Zhejiang medical institutions, associations, and different specialized committees to assess clinical topics on the therapeutic effects of anti-cancer products.
This year, also the first year of the program, cancer experts from five first-rate hospitals—Zhejiang Cancer Hospital, The First Affiliated Hospital, Zhejiang University, The Second Affiliated Hospital, Zhejiang University, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and Zhejiang Provincial Hospital of Chinese Medicine— applied 6 research topics.
“TCM technology has played a leading role in taking care of those who haven’t fallen ill yet, a synergistic role in the treatment of serious diseases, and critical role in recovery in recent years, which has been proved repeatedly in modern medical practice. From getting involved in the treatment of SARS and gaining excellent therapeutic effect with ‘zero infection, zero death, and zero sequela’ to Jinhua Qingganfang, and to cardiac care application in aerospace medicine… the dialectical therapeutic ideas of TCM, which pays much attention to the whole, addresses both symptoms and inner causes, and adjusts the balance of organism, have won the recognition and attention of the international community.
Having been promoted to over 180 countries and regions, TCM will for sure develop a brighter future and become more and more internationalized based on further research of researchers all over the world, making it another trump card to China’s international communication,” said LI Mingyan, President of ShouXianGu. He emphasized that it is the responsibility of every single TCM involver to let the world know TCM, experience TCM, admit TCM, and accept TCM.
ShouXianGu has kept focusing on the research and development of rare TCM such as Ganoderma lucidum and building a whole industrial chain development mode consisting of quality seed breeding, ecological organic planting, shredded herb processing, and intensive product processing in the past years.
We’ve worked with many first-rate scientific institutions at home and abroad, including Peking University, Zhejiang University, Mayo Clinic, Jean Dossey Lab, and National Cancer Institute of the United States, to make further research on dose-effect relationship, functioning mechanism, and quality control of Ganoderma lucidum through modern technology. Meanwhile, we’ve also taken the responsibility to draft and establish ISO standards of TCM Ganoderma lucidum and TCM Dendrobium officinale stem, gaining international right of speech for TCM circle.